Make a Donation
Help fund crucial research on ovarian and related gynecologic cancer.
Read more about Make a Donation Support better outcomes for patients
Ways to Give
Help us invest in life-saving research, offer hope and comfort to patients and their families, and continue to drive awareness and education.
Fundraise for OCRA
Channel your passion into action and fundraise for OCRA
Link: Links to main Make a Donation Page
Read more about Fundraise for OCRA Inspire hope through fundraising
Estate Planning
Including OCRA in your estate planning is an easy way to make a substantial impact, ensuring that your legacy lives on.
Read more about Estate Planning Learn about estate planning benefits
Workplace Giving
Did you know that many employers will match charitable donations made by their employees?
Stocks & Financial Gifts
Donating stocks, IRA distributions, or donor-advised funds is a great way to support OCRA. Ask us how to maximize the impact of your gift and your tax benefits.
Read more about Stocks & Financial Gifts Make a financial gift now
Other Ways to Give
Thanks to your support, we can continue to fund groundbreaking research, help patients and their loved ones through every step of their journey, and advocate on behalf of those who need it most.
Sponsor A Scientist
Our Partners in Science program offers donors the unique opportunity to fund research that speaks to their personal passions. By sponsoring a scientist of their choice (donors can choose based on an area of research, affiliated institution, or even a particular geographic region), they enjoy the satisfaction of supporting our most innovative and promising scientists, while also receiving updates on their sponsored scientist's progress and breakthroughs.
Partnership Opportunities
OCRA believes we are stronger together. Through strategic partnerships, we can maximize our impact and help find a cure for ovarian and all gynecologic cancers.
Corporate Partnerships
Demonstrate your company’s commitment to women’s health and life-saving research by creating a Corporate Partnership with OCRA as the beneficiary. Show your passion for supporting improved outcomes and quality of life for everyone touched by gynecologic cancer.
Industry Partnerships
Industry partnerships help ensure enhanced clinical research, more effective patient-centric treatments and diagnostic methods, and safer, beneficial therapies.
Related Topics
OCRA Sponsors NCCN Guidelines for Cervical, Ovarian, and Uterine Cancer Patients
This article was updated in April 2026 to reflect NCCN’s release of the 2026 Guidelines for Uterine Cancer Patients. OCRA is a proud sponsor of the 2026 Patient Guidelines for Cervical Cancer and Uterine Cancer, and the 2025 Patient Guidelines for Ovarian. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful … Continued
FDA Approves Lifyorli Plus Abraxane for Platinum-Resistant Ovarian Cancer
On March 25, 2026, the U.S. Food and Drug Administration (FDA) approved Lifyorli (relacorilant), made by Corcept Therapeutics, in combination with Abraxane (nab-paclitaxel) for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior lines of treatment, including prior Avastin (bevacizumab). The approval follows last month’s FDA … Continued
The Overview: March 2026
OCRA’s Annual Advocacy Day Draws Survivors and Caregivers from Across the Country More than 120 gynecologic cancer survivors, caregivers, researchers and supporters from nearly forty states filled the halls of the U.S. Capitol on Tuesday, March 17—dressed in teal, the color of ovarian cancer awareness—as Ovarian Cancer Research Alliance (OCRA) held its annual Spring Advocacy Day. The … Continued